Ausgabe 2/2019
Inhalt (9 Artikel)
Therapeutic targeting potential of chromatin-associated proteins in MLL-rearranged acute leukemia
Xin Xu, Björn Schneider
MicroRNA-mediated redox regulation modulates therapy resistance in cancer cells: clinical perspectives
Safieh Ebrahimi, Seyed Isaac Hashemy
Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma
Renata L. Markman, Liana P. Webber, Carlos H. V. Nascimento Filho, Leonardo A. Reis, Pablo A. Vargas, Marcio A. Lopes, Virgilio Zanella, Manoela D. Martins, Cristiane H. Squarize, Rogerio M. Castilho
Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation
Anmada Nayak, Sarita Das, Deepika Nayak, Chinmayee Sethy, Satya Narayan, Chanakya Nath Kundu
Secretome profiling of heterotypic spheroids suggests a role of fibroblasts in HIF-1 pathway modulation and colorectal cancer photodynamic resistance
María Julia Lamberti, Mandy Rettel, Jeroen Krijgsveld, Viviana Alicia Rivarola, Natalia Belén Rumie Vittar
SNHG6 is upregulated in primary breast cancers and promotes cell cycle progression in breast cancer-derived cell lines
Amin Jafari-Oliayi, Malek Hossein Asadi
Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells
Tetsuya Kokabu, Taisuke Mori, Hiroshi Matsushima, Kaori Yoriki, Hisashi Kataoka, Yosuke Tarumi, Jo Kitawaki
Nuclear localization of PD-L1: artifact or reality?
Hara Polioudaki, Amanda Chantziou, Konstantina Kalyvianaki, Panagiotis Malamos, George Notas, Dimitris Mavroudis, Marilena Kampa, Elias Castanas, Panayiotis A. Theodoropoulos